TLV · ENVM.TA
ENvizion Medical Ltd.
₪0.54+₪0.03 (+6.72%)
ENvizion Medical Ltd.’s quoted price sits in the lower half of its reported 52-week range, 97.29% below the high.
Loading market information…
TLV · ENDY.TA · ILA
Stock price, earnings
Quote as of Feb 10, 2025, 09:53 AM UTC. Cached market data; not a live quote.
One-year closing-price history · ILA. Historical prices are not a forecast.
Endymed Ltd’s quoted price sits in the upper half of its reported 52-week range, 9.83% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow Endymed Ltd’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Endymed Ltd is a medical technology company focused on the global design, development, and sale of energy-driven aesthetic treatment systems, catering to both professional practitioners and individual consumers. Its product offerings include the versatile EndyMed PRO, a platform capable of multiple applications. Another key product, PURE 2.0, provides professional-grade skin tightening, body contouring, and functional skin resurfacing. Furthermore, the firm leverages its proprietary 3DEEP radiofrequency technology to deliver a wide array of solutions for cosmetic enhancements, such as diminishing wrinkles, tightening skin, sculpting the body, improving texture, reducing cellulite and overall circumference, treating acne and related scarring, lessening stretch marks, performing RF microneedling, and fractional resurfacing. Established in 2007, the company is headquartered in Freehold, New Jersey.
Latest available per-share figures in ILS. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 10:27 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
₪0.54+₪0.03 (+6.72%)
ENvizion Medical Ltd.’s quoted price sits in the lower half of its reported 52-week range, 97.29% below the high.
₪6.13-₪0.15 (-2.39%)
Elbit Imaging Ltd.’s quoted price sits in the upper half of its reported 52-week range, 27.74% below the high.
₪2.70+₪0.05 (+1.81%)
Almeda Ventures Limited Partnership’s quoted price sits in the upper half of its reported 52-week range, 12.08% below the high.
₪0.39+₪0.04 (+11.43%)
Nextage Therapeutics Ltd’s quoted price sits in the upper half of its reported 52-week range, 49.35% below the high.
₪0.43+₪0.01 (+1.65%)
Cannassure Therapeutics Ltd’s quoted price sits in the upper half of its reported 52-week range, 19.85% below the high.
₪0.17+₪0.01 (+3.07%)
Erika B-Cure Laser Ltd’s quoted price sits in the lower half of its reported 52-week range, 44.55% below the high.
₪0.30-₪0.02 (-5.45%)
Human Xtensions Ltd.’s quoted price sits in the upper half of its reported 52-week range, 44.02% below the high.
₪2.68-₪0.16 (-5.64%)
Erech Finance Cahalacha Ltd’s quoted price sits in the lower half of its reported 52-week range, 70.04% below the high.